Showing results (1121-1130 of 5,010) with videos related to
Sort By:
Pageof 501
American Journal of Clinical Oncology|April 16, 1998
Phase I study of paclitaxel and etoposide for metastatic or recurrent malignanciesR C Lilenbaum, D MacManus, C Engstrom, et al.American Journal of Clinical Oncology|April 16, 1998
Octreotide does not prevent diarrhea in patients treated with weekly 5-fluorouracil plus high-dose leucovorinN J Meropol, L E Blumenson, P J CreavenAmerican Journal of Clinical Oncology|April 16, 1998
Combined levamisole with recombinant interleukin-2 (IL-2) in patients with advanced renal cell carcinoma: a phase II studyE T Creagan, R D Hestorff, V J Suman, et al.American Journal of Clinical Oncology|April 16, 1998
Treatment of acute myelogenous leukemia in the older patient with attenuated high-dose ara-CL Letendre, P Noel, M R Litzow, et al.American Journal of Clinical Oncology|April 16, 1998
Seventy-two hour epirubicin infusion plus quinidine in unresectable and metastatic adenocarcinoma of the pancreas: a phase II trialA Abad, B Massuti, E Blanco, et al.American Journal of Clinical Oncology|April 16, 1998
5-Fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer: an Eastern Cooperative Oncology Group phase II study (E1889)J D Berlin, K J Propert, D Trump, et al.American Journal of Clinical Oncology|April 16, 1998
A comparison of two nonsteroidal antiinflammatory drugs (diflunisal versus dipyrone) in the treatment of moderate to severe cancer pain: a randomized crossover studyS Yalçin, I H Güllü, G Tekuzman, et al.American Journal of Clinical Oncology|April 16, 1998
Preoperative radiotherapy for cancer of the extrahepatic bile ductS Hishinuma, Y Ogata, J Matsui, et al.American Journal of Clinical Oncology|April 16, 1998
Malignant thyroid teratoma of an adult: a long-term survival after chemotherapyJ S Chen, G M Lai, S HsuehAmerican Journal of Clinical Oncology|October 1, 1985
Chemotherapy of cervix cancer with doxorubicin and cisplatin. A phase I pilot study of the Gynecologic Oncology GroupG A Omura, J Hubbard, K HatchPageof 501